日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Emerging evidence supports direct-acting antiviral therapy for HCC patients beyond the early stage: Correspondence to editorial on "Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study"

新出现的证据支持对早期后阶段的肝细胞癌患者进行直接抗病毒治疗:对题为“对丙型肝炎病毒相关肝细胞癌患者进行直接抗病毒治疗:一项全国性队列研究”的社论的回应

Lee, Teng-Yu; Tsai, Pei-Chien; Lee, Shou-Wu; Yu, Ming-Lung

Revisiting unmet needs in clinical research on direct-acting antiviral therapy for HCC patients: Correspondence to letter to the editor on "Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study"

重新审视HCC患者直接抗病毒治疗临床研究中未满足的需求:对“HCV相关肝细胞癌患者的直接抗病毒治疗:一项全国性队列研究”一文的致编辑信函的回应

Lee, Teng-Yu; Tsai, Pei-Chien; Lee, Shou-Wu; Yu, Ming-Lung

Genome-wide association study identifies three PNPLA3/SAMM50 SNPs associated with HCC development in non-viral liver disease

全基因组关联研究发现,PNPLA3/SAMM50基因的三个单核苷酸多态性位点与非病毒性肝病中肝细胞癌的发生发展相关。

Liu, Xia-Rong; Yang, Tsai-Hsuan; Su, Tung-Hung; Yin, Szu-Ching; Chen, Yi-Ting; Chen, Fen-Fang; Pang, See-Tong; Hou, Ming-Chih; Peng, Yen-Chun; Yang, Shun-Fa; Huang, Peng-Ju; Lee, Sing-Lian; Chen, Ming; Huang, Chih-Yang; Chang, Ya-Hsuan; Chen, Hsuan-Yu; Yang, Hwai-I; Yu, Ming-Lung; Chen, Chien-Jen; Kao, Jia-Horng; Lee, Mei-Hsuan

Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia

肝细胞癌病因的时间趋势和区域差异:一项跨亚洲的多国研究

Takeuchi, Yasuto; Tateishi, Ryosuke; Obi, Shuntaro; Otsuka, Motoyuki; Mochizuki, Hitoshi; Jazag, Amarsanaa; Yokosuka, Osamu; Ogasawara, Sadahisa; Kanogawa, Naoya; Gonchig, Erdenebayar; Matsushita, Yuki; Kekilli, Murat; Bilican, Gulden; Kim, Yoon Jun; Hur, Moon Haeng; Yu, Ming-Lung; Huang, Chung-Feng; Morishita, Asahiro; Oura, Kyoko; Komori, Atsumasa; Motoyoshi, Yasuhide; Siregar, Lianda; Loho, Imelda; Yang, Ming; Okabe, Shuichirou; Ueno, Yoshiyuki; Katsumi, Tomohiro; Sato, Takahisa; Kogure, Hirofumi; Masuzaki, Ryota; Lesmana, Cosmas Rinaldi; Nababan, S H H; Nimanong, Supot; Huang, Yi-Hsiang; Nagamatsu, Hiroaki; Yoshida, Hideo; Uchino, Koji; Hasan, Irsan; Kitiyakara, Taya; Akamatsu, Masatoshi; Okamoto, Makoto; Kondo, Mayuko; Moriyama, Makoto; Sukeepaisarnjareon, Wattana; Tangkijvanich, Pisit; Thanapirom, Kessarin; Yalcin, Kendal; Kızıl, Hayriye Dilan; Adali, Gupse; Akdogan, Meral; Gokce, Dilara Turan; Balaban, Yasemin; Gokcan, Hale; Coşar, Arif Mansur; Harputluoglu, Murat; Bahçecioğlu, İbrahim Halil; Atasoy, Alp; Kockar, Muhammet Cem; Dursun, Hakan; Eminler, Ahmet Tarik; Sollano, Jose; Su, Dong Jin; Piratvisuth, Teerha; Kao, Jia-Horng; Crawford, Darrell; Hou, Jinlin; Sharma, Barjesh Chander; Payawal, Diana Alcantara; Gani, Rino Alvani; Tanwandee, Tawesak; Yang, Jin Mo; Lin, Han-Chieh; Shiina, Shuichiro; Jia, Ji-Dong; Lau, George; Örmeci, Necati; Dokmeci, A Kadir; Wei, Lai; Sarin, Shiv Kumar; Omata, Masao

Artificial Intelligence Applications in the Diagnosis, Treatment, and Prognosis of Hepatocellular Carcinoma

人工智能在肝细胞癌的诊断、治疗和预后中的应用

Lu, Ming-Ying; Wu, Jacky Chung-Hao; Lu, Henry Horng-Shing; Eslam, Mohammed; Yu, Ming-Lung

Metabolic Dysfunction-Associated Steatotic Liver Disease After Hepatitis C Virus Cure

丙型肝炎病毒治愈后代谢功能障碍相关性脂肪肝疾病

Huang, Chung-Feng; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long

The Proteomic Profiling of Circulating Extracellular Vesicles of Western Diet and Chemical-Induced Murine MASH Model

西方饮食和化学诱导的小鼠MASH模型循环细胞外囊泡的蛋白质组学分析

Wang, Szu-Jen; Wang, Yung-Ho; Huang, Jee-Fu; Lin, En-Sheng; Chen, Wei-Shiun; Li, Chia-Yang; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung; Wang, Shu-Chi

Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?: Correspondence to editorial on "Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan"

慢性丙型肝炎相关肝细胞癌中的脂肪肝:是罪魁祸首还是旁观者?:对“慢性丙型肝炎患者病毒清除后代谢功能障碍相关脂肪肝的动态变化:台湾全国登记研究”一文的社论的回应

Huang, Chung-Feng; Yeh, Ming-Lun; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung

Reconsidering treatment indications for chronic hepatitis B: Insights from the TORCH-B roll-over study: Editorial on "Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial"

重新审视慢性乙型肝炎的治疗指征:来自 TORCH-B 延续研究的启示:关于“轻度转氨酶升高慢性乙型肝炎的抗病毒治疗:TORCH-B 试验的延续研究”的社论

Wang, Chih-Wen; Yu, Ming-Lung

Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study

直接抗病毒疗法治疗丙型肝炎病毒相关肝细胞癌患者:一项全国性队列研究

Lee, Shou-Wu; Yang, Sheng-Shun; Tsai, Pei-Chien; Huang, Chung-Feng; Chen, Chi-Yi; Hung, Chao-Hung; Chen, Chien-Hung; Tai, Chi-Ming; Cheng, Pin-Nan; Kuo, Hsing-Tao; Tseng, Kuo-Chih; Mo, Lein-Ray; Lo, Ching-Chu; Huang, Yi-Hsiang; Lin, Han-Chieh; Lee, Pei-Lun; Bair, Ming-Jong; Chang, Te-Sheng; Lin, Chun-Yen; Wang, Szu-Jen; Hsieh, Tsai-Yuan; Yang, Tzeng-Hue; Peng, Cheng-Yuan; Yang, Chi-Chieh; Chong, Lee-Won; Huang, Chien-Wei; Lin, Chih-Wen; Chu, Cheng-Hsin; Tsai, Ming-Chang; Kao, Jia-Horng; Liu, Chun-Jen; Chuang, Wan-Long; Lee, Teng-Yu; Yu, Ming-Lung